Di Carlo Lab technologies have contributed to FDA-cleared diagnostics, clinical-stage biomaterials, commercial single-cell analysis products, and platforms used across academia, biotechnology, and pharmaceutical research.
Nanovial and Cell-Cell-seq platforms are designed to capture defined cell pairs, measure interaction outcomes, and connect functional behavior to molecular state.
Ferrobotics and lab-on-a-3D-printer systems point toward lower-cost, programmable laboratory workflows for research, diagnostics, and education.
Nature Protocols (2025)
Nature Nanotechnology (2024)
Nature Communications (2024)
Nature Communications (2024)
PNAS (2024)
